| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |